Lexinfintech Holdings Ltd (LX) Stock News

Scilex Holding Company shares surged 18.79% after announcing that its Dream Bowl I Meme Coin tokens will begin trading on Biconomy Exchange as early as June 23. The listing is expected to improve liquidity and enable broader distribution for eligible token holders. Scilex is a biotech company focused on non-opioid pain management products.

Rosen Law Firm is notifying investors in Roblox Corporation, Zoetis Inc., and Barclays PLC of ongoing securities class action lawsuits. The firm is seeking lead plaintiffs with an August 7, 2026 deadline. The Roblox case alleges the company made false statements about organic growth potential while concealing material adverse facts about enrollment verification impacts.

Rosen Law Firm is reminding investors who purchased Calix, Inc. securities between January 28, 2026 and April 21, 2026 of an important July 27, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Calix made false and misleading statements regarding its margins, claiming the company benefited from advanced memory component purchasing that was subsequently depleted, forcing it to purchase components at rising market prices, which negatively impacted margins.

Robbins LLP filed a class action lawsuit against Roblox Corporation, alleging the company misled investors about the impact of its age verification rollout on user growth and fiscal 2026 performance. Roblox provided optimistic guidance of 22-26% bookings growth in February 2026 but subsequently slashed it to 8-12% in April 2026, citing significant negative impacts from the age verification feature. The stock declined 18.33% following the announcement.

Robbins LLP filed a class action lawsuit against Calix, Inc. (CALX) on behalf of investors who purchased securities between January 28, 2026 and April 21, 2026. The lawsuit alleges that Calix misled investors by failing to disclose that its first quarter margins benefited from advanced memory component purchasing and that this supply was dwindling, resulting in negative margin pressure. Following the disclosure of declining gross margin guidance on April 21, 2026, CALX stock fell 13.98%. Shareholders can participate in the class action with no fees or expenses.

LXP Industrial Trust announced a quarterly common share dividend of $0.70 per share payable on July 15, 2026, for the quarter ending June 30, 2026. The REIT also declared a dividend of $0.8125 per share for its Series C Cumulative Convertible Preferred Stock payable on August 17, 2026.

Roblox Corporation (RBLX) faces a securities class action lawsuit after reporting a significant sequential decline in daily active users in Q1 2026, attributed to its age verification rollout. The stock plunged 18% ($10.13), erasing $6.7 billion in market capitalization. The lawsuit alleges the company made false and misleading statements about the age-check rollout's impact, claiming management knew of adverse consequences but assured investors of smooth implementation.

Rosen Law Firm has filed a class action lawsuit against Roblox Corporation on behalf of investors who purchased common stock between October 30, 2025 and April 30, 2026. The lawsuit alleges that Roblox provided misleading statements about its organic growth potential while concealing material adverse facts, including a significant slowdown in growth rates due to age verification rollout impacts, reduced on-platform communication, and declining app store ratings. Investors who suffered damages may be entitled to compensation.

Faruqi & Faruqi, LLP is investigating securities fraud claims against Roblox Corporation, alleging the company made false and misleading statements about its organic growth potential while concealing the negative impact of its age verification rollout. The lawsuit covers investors who purchased RBLX securities between October 30, 2025 and April 30, 2026. On April 30, 2026, Roblox announced disappointing Q1 results with slashed bookings guidance (8-12%) and revealed age verification adoption impacts were far greater than previously disclosed, causing the stock to plummet 18.33% in a single day from $55.26 to $45.13 per share. The deadline to seek lead plaintiff appointment is August 7, 2026.

Faruqi & Faruqi, LLP is investigating securities fraud claims against Calix, Inc., alleging the company made false statements about Q1 2026 margins by concealing that strong results were artificially inflated by advanced memory component purchasing. When the company disclosed on April 21, 2026 that its advanced supply had depleted and it would face rising market prices, CALX stock fell 13.98%. The deadline to seek lead plaintiff status is July 27, 2026.

Law Offices of Howard G. Smith has announced securities fraud class action lawsuits against four publicly-traded companies. Calix faces allegations of misleading statements regarding margin pressures from memory component costs. AeroVironment is accused of overstating business prospects amid competitive threats. Zoetis is alleged to have concealed weakening demand for key products due to safety concerns and market competition. Lucid Group is charged with failing to disclose supplier quality issues affecting vehicle deliveries. All cases have lead plaintiff deadlines in late July 2026.

Rosen Law Firm has filed a class action lawsuit on behalf of Roblox Corporation investors who purchased stock between October 30, 2025 and April 30, 2026. The lawsuit alleges that Roblox provided misleading statements about its organic growth potential, concealing material facts about significant slowdowns in growth rates due to age verification rollout impacts, reduced on-platform communication, and declining app store ratings. Investors who purchased during this period may be eligible for compensation. The deadline to serve as lead plaintiff is August 7, 2026.

Robbins Geller announces a class action lawsuit against Roblox Corporation for alleged securities fraud. The lawsuit claims Roblox made false statements about bookings growth and minimized risks associated with its age verification rollout. On April 30, 2026, Roblox reported significant declines in revenue guidance, bookings growth, engagement, and app ratings, causing the stock to fall over 18%. Investors with substantial losses can seek appointment as lead plaintiff by August 7, 2026.

Calix, Inc. (CALX) faces a securities class action lawsuit after disclosing on April 21, 2026 that its record gross margins were artificially inflated by dwindling pre-purchased memory components. The stock fell $6.93 per share (13.98%) following the admission. Investors who purchased CALX securities between January 28 and April 21, 2026 have until July 27, 2026 to seek lead plaintiff appointment in the class action.

A securities class action has been filed against Roblox Corporation for allegedly providing misleading statements about organic growth potential while concealing material adverse facts regarding age verification rollout impacts. The company's stock declined 18.33% on May 1, 2026, following the announcement of significantly reduced bookings growth guidance (8-12%) and lower margin expectations. Investors who purchased securities between October 30, 2025 and April 30, 2026 have until August 7, 2026 to seek lead plaintiff status.

Holzer & Holzer, LLC announced lead plaintiff deadlines for shareholder class action lawsuits against Calix, Inc., AeroVironment, Inc., and Lucid Group, Inc. The lawsuits allege materially false and misleading statements regarding advanced purchasing of memory components, competitive landscape misrepresentations, and manufacturing/delivery capability discrepancies. Investors who purchased shares during the specified periods and suffered losses are encouraged to seek legal representation.

Rosen Law Firm is reminding investors who purchased Calix, Inc. securities between January 28, 2026 and April 21, 2026 of the July 27, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Calix made false and misleading statements regarding its margins, claiming the company benefited from advanced memory component purchases that were dwindling, leading to negative margin pressure and materially misleading statements about business prospects.

Grabar Law Office has filed multiple federal securities fraud class action complaints against Badger Meter, Calix, New Era Energy & Digital, and Power Solutions International, alleging that officers and directors made false or misleading statements about financial performance, business operations, and growth prospects. Shareholders who purchased shares during specified periods may seek corporate reforms and compensation.

Class action lawsuits have been filed against Calix, AeroVironment, and Zoetis for allegedly making false or misleading statements about their financial performance and business prospects. Investors have until July 27, 2026 to file lead plaintiff motions in these securities fraud cases.

A securities fraud class action lawsuit has been filed against Calix, Inc. on behalf of investors who purchased securities between January 28, 2026 and April 21, 2026. The lawsuit alleges the company failed to disclose that its first quarter margins benefited from advanced memory component purchasing and that this supply was dwindling, leading to negative margin pressure. Following the April 21 earnings report revealing lower gross margin guidance, Calix shares declined approximately 14% from $49.58 to $42.65. Investors have until July 27, 2026 to request lead plaintiff appointment.

Rosen Law Firm has filed a class action lawsuit against Calix, Inc. on behalf of investors who purchased securities between January 28, 2026 and April 21, 2026. The lawsuit alleges that Calix made false and misleading statements regarding its profit margins, claiming the company benefited from advanced memory component purchases in Q1 but failed to disclose that supplies were dwindling and the company faced negative margin pressure from rising component costs. Investors who wish to serve as lead plaintiff must file by July 27, 2026.

BingEx reported flat Q4 2025 revenue of RMB 1 billion but achieved strong profitability improvements with non-GAAP net income surging 107% year-over-year to RMB 41.6 million. The company improved gross margins to 10.8% through operational refinement and strategic focus on high-value delivery segments like electronics (up 17% YoY) and cake delivery (up 5% YoY). BingEx expanded its network to 298 cities with 31 million riders and launched drone delivery pilots in Hangzhou with over 2,000 orders completed, while deploying AI across operations to boost development efficiency by 30%.

Calix, Inc. faces a securities class action lawsuit for allegedly concealing that record gross margins between January-April 2026 were temporarily sustained by pre-purchased lower-cost memory components. The company failed to disclose margin pressures until April 21, 2026, when it revealed declining margins due to exhausted inventory and rising memory costs, triggering a 13.98% stock decline. Investors who purchased shares during the class period may be eligible for damages.

Monopar Therapeutics announced Phase 2 trial results for ALXN1840 (tiomolibdate choline) in treatment-experienced Wilson disease patients. The study demonstrated stabilization or improvement in liver pathology across multiple histologic measures, significant neurologic improvements in UWDRS scores, and improved quality of life. The drug was generally well tolerated with mostly Grade 1-2 adverse events.

Rosen Law Firm has filed a class action lawsuit against Calix, Inc. on behalf of investors who purchased securities between January 28, 2026 and April 21, 2026. The lawsuit alleges that Calix made false and misleading statements regarding its margins, claiming the company benefited from advanced memory component purchasing in Q1 but failed to disclose that supplies were dwindling and the company faced negative margin pressure from rising component costs. Investors who wish to serve as lead plaintiff must file by July 27, 2026.

Bernstein Liebhard LLP has announced shareholder class action lawsuits against three companies: Calix (CALX) for alleged misrepresentations regarding business operations and financial stability during January-April 2026; AeroVironment (AVAV) for shareholders between June 2025 and March 2026; and Zoetis (ZTS) for shareholders between January 2025 and May 2026. Investors are encouraged to contact the firm to discuss their rights and potential recovery.

Rosen Law Firm has filed a class action lawsuit on behalf of Calix, Inc. investors who purchased securities between January 28, 2026 and April 21, 2026. The lawsuit alleges that Calix made false and misleading statements regarding profit margins, claiming the company benefited from advanced memory component purchasing in Q1 but failed to disclose that supplies were dwindling and the company faced negative margin pressure from rising component costs. Investors who suffered losses are encouraged to join the class action by July 27, 2026.

SHENZHEN, China , May 20, 2026 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE: RLX ), a leading global branded e-vapor company, today announced its unaudited financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Highlights Net revenues were RMB1,585.8 million (US$229.9 million) in the first quarter of 2026, increasing by 96.2% from RMB808.3 million in the same period of 2025. Gross margin was 31.8% in the first quarter of 2026, compared with 28.6% in the same period of 2025. Non-GAAP income from operations [1] was RMB310.3 million (US$45.0 million) in the first quarter of 2026, increasing by 187.9% from RMB107.8 million in the same period of 2025. U.S. GAAP net income was RMB294.2 million (US$42.6 million) in the first quarter of 2026, increasing by 32.1% from RMB222.7 million in the same period of 2025. Non-GAAP net income [1] was RMB357.3 million (US$51.8 million) in the first quarter of 2026, increasing by 41.4% from RMB252.7 million in the same period of 2025. "We began this year with robust first-quarter results, underpinned by a highly scalable global ecosystem and our ability to capture emerging market opportunities," said Ms. Ying (Kate) Wang, Co-founder, Chairperson, and Chief Executive Officer of RLX Technology. "We continued to accelerate our international expansion and broaden our global operations. Notably, we refined our user-first approach through highly localized strategies and deep engagement with trusted regional business partners to ensure superior product-market fit, strengthening our global competitiveness. We also integrated our R&D, manufacturing, and commercial operations into Nexus, our cutting-edge hub that is driving greater supply chain efficiencies while allowing us to seamlessly meet rising demand. Looking ahead, we will build on this momentum by focusing on innovativ

Telix Pharmaceuticals announced completion of patient enrolment in the IPAX-2 Phase 1 study of TLX101-Tx (¹³¹I-iodofalan) for newly diagnosed glioblastoma. The study reached its maximum dose of 10GBq with no dose-limiting toxicities observed. The company is also advancing the pivotal IPAX BrIGHT Phase 3 trial for recurrent glioblastoma, marking the first radiopharmaceutical therapy to enter Phase 3 development for this indication.

Law firm Kirby McInerney LLP is investigating Calix, Inc. for potential securities law violations following the company's April 21, 2026 earnings report. Calix reported declining gross margins and warned of further margin compression due to exhausted advanced supply purchases, causing the stock to drop 14% ($6.93 per share) on April 22, 2026. The firm is seeking investors who purchased Calix securities to discuss potential claims.